Using a combination of new generation long- and short-read sequencing technologies, this study analyses cancer samples for gene fusion transcripts. The approach uncovers transcripts arising from known gene fusions in leukaemia and prostate cancer, as well as newly discovered ones in prostate cancer.
- Christopher A. Maher
- Chandan Kumar-Sinha
- Arul M. Chinnaiyan